ROXBORO, N.C., March 1, 2021 /PRNewswire/ -- Open Book Extracts
(OBX), a Roxboro, N.C.-based
manufacturer, distributor, and formulator of the industry's most
innovative and high-quality cannabinoid ingredients and finished
products has announced the appointment of four strategic advisors
to support and accelerate industry-specific research initiatives
and boost its post-development commercialization efforts.
The newly appointed advisors are respected experts in their
fields with experience as researchers, executives, and
entrepreneurs.
Dave Wood, who most
recently served as the chief executive officer (CEO) of Captek, the
largest dietary supplement softgel manufacturer in North America, will serve as nutraceutical
advisor. Wood possesses over 30 years of management experience with
an emphasis on pharmaceutical-grade manufacturing, research and
development, and licensing, with a deep background in the
nutritional supplement sector.
Cosmeceutical advisors are Dr. Jeffrey Dover, MD, FRCPC, co-director of
SkinCare Physicians of Chestnut
Hill, a comprehensive facility specializing in dermatology,
laser, and cosmetic surgery, where he has been named as a Top
Doctor in Boston for 16 years. Dr.
Dover also serves as associate professor of Clinical Dermatology at
Yale University School of Medicine, and
associate professor of Dermatology at Brown Medical School, with
research focus areas in Photomedicine, lasers in medicine, cosmetic
laser surgery, and medical education, and Dr. Michael Singer, MD, PhD, a serial biotech
executive and chief scientific officer at Cartesian Therapeutics, a
clinical-stage biotechnology company and leader in mRNA-engineered
cell therapies.
Veterinary advisor is Dr. Robert
Silver, DVM, MS, a licensed and nationally renowned
integrative veterinarian, and one of the leading experts on
veterinary health and medical cannabis. He is the author of
Medical Marijuana and Your Pet and has recently authored
four chapters in two Springer-Nature textbooks on Veterinary
Cannabis. Dr. Silver holds adjunct faculty positions at
Lincoln Memorial University's College
of Veterinary Medicine, and the Chi University of Traditional
Chinese Veterinary Medicine and is president-elect of the American
College of Veterinary Botanical Medicine.
"Each appointee joining OBX from sectors outside the cannabis
category is a testament to the broad appeal of the industry and the
unique opportunity to make an impact through OBX," said
Dave Neundorfer co-founder and CEO
of Open Book Extracts.
"Bringing diverse skill sets and successful careers in
pharmaceutical-grade manufacturing, consumer healthcare, gene
therapies, veterinary medicine, cosmeceutical development,
intellectual property and patent strategy, the advisors are already
actively engaged in advancing OBX's vision of delivering
innovative, research-backed products to lead the way for
cannabinoid-enabled health and wellness," added Neundorfer.
OBX is dedicated to bringing safe and effective products to
market. While much of the company's product development work is
client-guided, OBX has recently embarked on several of its own
research-backed product development initiatives, targeting the
nutraceutical, skincare, and veterinary markets. OBX expects to
commercialize its findings through licensing deals and/or joint
venture partnerships with well-known, widely distributed consumer
brands.
The appointments follow the company's announcement of their
reciprocal research collaboration with Case
Western Reserve University School of Medicine (CWRU) to
explore the mechanistic effects of cannabinoids on brain cell
function. Powered by their cGMP operations and a team of world
class scientists, OBX offers one of the largest portfolios of
cannabinoid isolates, including CBD, CBG, CBN, CBC, and THCV, all
at greater than 99% purity, as well as formulation services and
turnkey finished good manufacturing including edibles, softgels,
tablets, tinctures, and a full range of topical products.
"I am delighted to join OBX as an advisor because they sit at
the intersection of what matters most today – high-quality
ingredient production, expert formulation services, and
best-class-in finished products, development and innovation," said
Wood. "OBX is a prominent company in the cannabinoid industry
and I look forward to supporting their role in accelerating the
path to market success for clients around the world."
Neundorfer also noted, "As OBX gears up for a substantial growth
phase, the depth and breadth of expertise our advisors will
contribute from the pharmaceutical, nutraceutical, veterinary, and
dermatology industries will bring tremendous value to our
organization and the larger OBX ecosystem as we enhance and expand
our capabilities."
Open Book Extracts is a cGMP-certified manufacturer of premium
plant-based cannabinoid products, aiming to be the industry's true
north by delivering premium products, exceptional service, and
industry-leading transparency. With control of the entire supply
chain, a state-of-the-art extraction campus near North Carolina's Research Triangle,
proprietary refinement and conversion methods backed by a growing
IP portfolio, and a team of PhD chemists and seasoned business
leaders, OBX is the trusted partner for global brands seeking to
enter the marketplace. OBX Asia, with its headquarters in
Hong Kong, provides strategic
guidance and on-the-ground support for its Asia customers. For additional company and
product information, visit https://www.openbookextracts.com.
For more information contact:
Sheldon Baker
559-287-7191
300875@email4pr.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/open-book-extracts-appoints-four-new-strategic-corporate-advisors-301237435.html
SOURCE Open Book Extracts
